Mode
Text Size
Log in / Sign up

Uterine prolapse

Part of Pelvic organ prolapse

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for uterine prolapse

8 trials tracked for uterine prolapse: 5 in phase 3 or 4 and 1 with published results. The most-cited published study has 23 citations.

8Trials tracked
5Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 5 Other / NA 3
  1. Phase 4 Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen Completed · 23 cited
  2. Phase 4 Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Completed
  3. Phase 4 Efficacy Study of Vaginal Mesh for Anterior Prolapse Completed
  4. Phase 4 Lessons on Urethral Lidocaine in Urodynamics Completed
  5. Phase 4 Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair Completed
  6. N/A Efficacy Study of Vaginal Mesh for Prolapse Completed
Show 2 more trials
  1. N/A A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension Completed
  2. N/A Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Uterine prolapse: what the trials found

Surgical interventions for uterine prolapse show varying results regarding anatomical success and complication rates. Synthetic polypropylene mesh was evaluated for anterior prolapse, with a reported objective treatment success rate of 10% to 12% at one year 3. Grafted anterior prolapse repair demonstrated significantly lower rates of recurrent Stage II or greater anterior vaginal prolapse (11% vs. 24%, p=0.005) compared to other methods, while showing no significant difference in operative time (p=0.5) but a statistically significant difference in vaginal mesh exposure (p<0.05) 5.

Pharmacological and supportive interventions provide different clinical outcomes. Conjugated Estrogens Cream was evaluated in a Phase 4 study 1. Water-based vaginal lubricants were associated with voiding efficiency metrics of 94.6% and 95.9% 2. In surgical settings involving Rocuronium, peak airway pressures showed significant variation (p=0.01), while abdominal insufflation pressure and surgical rating scales did not show statistically significant differences (p=0.28, p=0.63 respectively) 4.

Recent results — preliminary, needs further review

  • Synthetic monofilament polypropylene mesh was associated with an anatomic cure at 3 years in a subset of patients (p<0.05) 6.
  • Preoperative pessary use was associated with significant improvements in both prolapse symptom severity and the bother of bladder/vaginal/bowel symptoms (p=0.001) 7.
  • The use of absorbent suture (polydioxanone) combined with permanent suture (Gore-Tex CV2) was evaluated regarding POP-Q Point C measurements 8.

For the clinician treating this condition

  • Grafted anterior prolapse repair significantly reduces the rate of recurrent Stage II or greater anterior vaginal prolapse compared to other surgical techniques 5.
  • Surgical outcomes for synthetic polypropylene mesh show specific success rates for anatomical correction at one year 3.
  • Preoperative pessary use is associated with significant improvements in patient-reported symptom severity and related bothers 7.

AI synthesis of 8 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Pelvic organ prolapse

Related studies from across the Pelvic organ prolapse family.